NZD 2.65
(1.92%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 77.46 Million NZD | 3.57% |
2023 | 74.79 Million NZD | 15.04% |
2022 | 65.01 Million NZD | -5.15% |
2021 | 68.54 Million NZD | -1.8% |
2020 | 69.79 Million NZD | 19.3% |
2019 | 58.5 Million NZD | 18.76% |
2018 | 49.26 Million NZD | 27.09% |
2017 | 38.76 Million NZD | 16.05% |
2016 | 33.4 Million NZD | 7.08% |
2015 | 31.19 Million NZD | 39.13% |
2014 | 22.41 Million NZD | 25.2% |
2013 | 17.9 Million NZD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 FY | 77.46 Million NZD | 3.57% |
2024 Q3 | 77.46 Million NZD | -8.83% |
2024 Q1 | 84.96 Million NZD | 13.6% |
2024 Q4 | 77.46 Million NZD | 0.0% |
2024 Q2 | 84.96 Million NZD | 0.0% |
2023 Q3 | 74.79 Million NZD | 10.18% |
2023 Q4 | 74.79 Million NZD | 0.0% |
2023 FY | 74.79 Million NZD | 15.04% |
2023 Q1 | 67.88 Million NZD | 4.41% |
2023 Q2 | 67.88 Million NZD | 0.0% |
2022 Q1 | 64.61 Million NZD | -5.74% |
2022 Q4 | 65.01 Million NZD | 0.0% |
2022 Q3 | 65.01 Million NZD | 0.63% |
2022 FY | 65.01 Million NZD | -5.15% |
2022 Q2 | 64.61 Million NZD | 0.0% |
2021 Q2 | 64.09 Million NZD | 0.0% |
2021 Q1 | 64.09 Million NZD | -8.17% |
2021 Q3 | 68.54 Million NZD | 6.94% |
2021 Q4 | 68.54 Million NZD | 0.0% |
2021 FY | 68.54 Million NZD | -1.8% |
2020 Q4 | 69.79 Million NZD | 0.0% |
2020 Q2 | 68.64 Million NZD | 0.0% |
2020 Q1 | 68.64 Million NZD | 17.34% |
2020 FY | 69.79 Million NZD | 19.3% |
2020 Q3 | 69.79 Million NZD | 1.67% |
2019 Q4 | 58.5 Million NZD | 0.0% |
2019 FY | 58.5 Million NZD | 18.76% |
2019 Q3 | 58.5 Million NZD | 3.65% |
2019 Q2 | 56.44 Million NZD | 0.0% |
2019 Q1 | 56.44 Million NZD | 14.59% |
2018 Q1 | 37.03 Million NZD | -4.44% |
2018 Q4 | 49.26 Million NZD | 0.0% |
2018 Q3 | 49.26 Million NZD | 33.0% |
2018 Q2 | 37.03 Million NZD | 0.0% |
2018 FY | 49.26 Million NZD | 27.09% |
2017 FY | 38.76 Million NZD | 16.05% |
2017 Q2 | 35.75 Million NZD | 0.0% |
2017 Q1 | 35.75 Million NZD | -3.56% |
2017 Q3 | 38.85 Million NZD | 8.67% |
2017 Q4 | 38.76 Million NZD | -0.24% |
2016 Q3 | 37.07 Million NZD | 0.93% |
2016 Q2 | 36.73 Million NZD | 0.0% |
2016 FY | 33.4 Million NZD | 7.08% |
2016 Q4 | 37.07 Million NZD | 0.0% |
2016 Q1 | 36.73 Million NZD | 17.76% |
2015 Q4 | 31.19 Million NZD | 0.0% |
2015 Q1 | - NZD | 0.0% |
2015 Q3 | 31.19 Million NZD | 0.0% |
2015 FY | 31.19 Million NZD | 39.13% |
2014 FY | 22.41 Million NZD | 25.2% |
2013 FY | 17.9 Million NZD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Greenfern Industries Limited | 1.28 Million NZD | -5929.255% |
Rua Bioscience Limited | 973.12 Thousand NZD | -7860.128% |